| 标题 |
Clinical pharmacology strategies to support dose optimization of the recommended Phase 2 dose regimen of JNJ-5322, a BCMA×GPRC5D×CD3 trispecific antibody, in Relapsed/Refractory multiple myeloma |
| 网址 | |
| DOI |
10.1182/blood-2025-4054
doi
|
| 其它 |
期刊:Blood 作者:Ashley Nguyen; Jie Zhou; Thomas Prior; Joseph Weidman; Sangmin Lee; et al 出版日期:2025-11-03 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)